Ratings Swiss Re Ltd Deutsche Boerse AG

Equities

SR9

CH0126881561

Delayed Deutsche Boerse AG Other stock markets 10:20:52 2019-06-28 am EDT			5-day change	1st Jan Change
89.02 ^EUR	+1.04%		-.--%	-.--%

Apr. 22	Swiss Re to Roll Out AI-Powered Insurance Underwriting Assistant	MT
Apr. 15	Swiss Re Appoints New Chairman	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

With a P/E ratio at 7.89 for the current year and 7.22 for next year, earnings multiples are highly attractive compared with competitors.
With regards to fundamentals, the enterprise value to sales ratio is at 0.69 for the current period. Therefore, the company is undervalued.
The company is one of the best yield companies with high dividend expectations.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Reinsurance

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SWISS RE LTD	-.--%	31.62B		-
GENERAL INSURANCE CORPORATION OF INDIA	+12.29%	7.27B		-
BROOKFIELD REINSURANCE LTD.	-0.40%	5.85B	-	-
ENSTAR GROUP LIMITED	-1.17%	4.26B	-	B
KOREAN REINSURANCE COMPANY	+14.55%	871M		C-
CENTRAL REINSURANCE CORPORATION	+17.57%	665M	-	-
POZAVAROVALNICA SAVA, D.D.	+7.86%	500M	-	-
MNRB HOLDINGS	+43.44%	287M		B-
HELIOS UNDERWRITING PLC	+16.72%	165M	-	-
VIETNAM NATIONAL REINSURANCE CORPORATION	+2.67%	152M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes